Peter Thiel-backed ATAI launches new Salvia-focused biotech; Purdue bankruptcy trial expected to begin today — report
ATAI Life Sciences, the Peter Thiel-backed umbrella developer of psychedelics and other drugs for mental health conditions, launched a new portfolio company Thursday.
The new …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.